Nystatin And Triamcinolone Acetonide
NDC Package 53002-9360-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nystatin And Triamcinolone Acetonide is cream and Ointment are indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment. Marketed by Rpk Pharmaceuticals, Inc., this product is identified by NDC 53002-9360 and is authorized under FDA application ANDA062364.

Identification & Billing

NDC Package Code
53002-9360-2
Package Description
30 g in 1 TUBE
Product Code
53002-9360
11-Digit Billing Format
53002936002
RxNorm Crosswalk
  • RxCUI: 1053753 - nystatin 100,000 UNT/GM / triamcinolone acetonide 1 MG/GM Topical Cream
  • RxCUI: 1053753 - nystatin 100000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream
  • RxCUI: 1053753 - nystatin 100,000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Nystatin And Triamcinolone Acetonide
Dosage Form
-
Usage Information
Nystatin and Triamcinolone Acetonide Cream and Ointment are indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.

Regulatory & Marketing

Labeler Name
Rpk Pharmaceuticals, Inc.
FDA Application #
ANDA062364
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-22-1987
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (53002-9360). Click a package code to view its specific billing and regulatory data.

53002-9360-1
15 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53002-9360-2 identifies a specific commercial package of 30 g in 1 tube of Nystatin And Triamcinolone Acetonide, labeled by Rpk Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rpk Pharmaceuticals, Inc. on December 22, 1987. The current certification is valid through December 31, 2024.

How is this Rpk Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53002936002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53002-9360-2
11-Digit CMS (5-4-2)
53002-9360-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.